Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPRING: Induction Chemotherapy for Neuroblastoma Without Prophylactic G-CSF
NCT02786719Completed
- Sponsor
- Baylor College of Medicine
- Start
- Jun 2016
- Primary completion
- Feb 2019
- Modality
- Monoclonal Antibodies, Targeted Liposomes, Stealth (PEGylated) Liposomes
- Countries
- 1
01
Overview
Open-label trial of topotecan liposome, cyclophosphamide, Cisplatin micelle injection (HA132), etoposide, vincristine sulfate liposome injection and 1 more in neuroblastoma, sponsored by Baylor College of Medicine. Started Jun 2016; status: completed.
02
Drugs
topotecan liposomecyclophosphamideCisplatin micelle injection (HA132)etoposidevincristine sulfate liposome injection
03
Conditions
neuroblastoma
Beyond the preview
Go deeper on NCT02786719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02786719.